Home > Boards > US Listed > Medical - Drugs > Antares Pharma, Inc. (ATRS)

SOS continues to be Bullish on ATRS

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
H2R Member Profile
 
Followed By 15
Posts 1,521
Boards Moderated 0
Alias Born 07/17/14
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 1:19:20 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/11/2020 7:08:02 AM
Antares Pharma Announces Full-Year 2020 Net Revenue Guidance Range of $135 to $155 Million GlobeNewswire Inc. - 1/27/2020 7:00:10 AM
Antares Pharma Appoints Edward Tykot Senior Vice President, Corporate Development GlobeNewswire Inc. - 12/10/2019 7:00:10 AM
Antares Pharma Social Media Campaign for XYOSTED® Wins MarCom Platinum Award GlobeNewswire Inc. - 12/6/2019 7:00:10 AM
Antares Pharma to Present at the 31st Annual Piper Jaffray Healthcare Conference GlobeNewswire Inc. - 11/27/2019 5:51:22 PM
Antares Pharma Enters Into a Global Development Agreement With Idorsia Pharmaceuticals Ltd. GlobeNewswire Inc. - 11/19/2019 7:00:00 AM
Antares Pharma Enters Into a Global Development Agreement With Idorsia Pharmaceuticals Ltd. GlobeNewswire Inc. - 11/19/2019 1:00:00 AM
Antares Pharma to Present at the Jefferies 2019 London Healthcare Conference GlobeNewswire Inc. - 11/13/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2019 4:16:28 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2019 7:31:28 AM
Antares Pharma Reports Third Quarter 2019 Operating and Financial Results GlobeNewswire Inc. - 11/5/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/4/2019 7:02:13 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/4/2019 7:00:22 AM
Antares Pharma Announces Receipt of Final Payment From Sale of Zomajet™ Needle-Free Delivery System GlobeNewswire Inc. - 10/31/2019 7:00:05 AM
Antares Pharma to Report Third Quarter 2019 Financial and Operating Results GlobeNewswire Inc. - 10/29/2019 7:00:05 AM
Gazit Globe Offer to Acquire All Minority Shareholder Interests in Subsidiary Atrium Has Not Been Approved GlobeNewswire Inc. - 10/25/2019 10:41:10 AM
Antares Pharma Announces Two Poster Presentations at the 2019 Sexual Medicine Society Scientific Annual Meeting GlobeNewswire Inc. - 10/24/2019 7:00:05 AM
Gazit Globe Reaffirms its Commitment and Price GlobeNewswire Inc. - 10/11/2019 2:41:57 PM
Antares Pharma to Present at the Ladenburg Thalmann 2019 Healthcare Conference GlobeNewswire Inc. - 9/17/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2019 5:01:34 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2019 4:02:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2019 7:06:56 AM
Antares Pharma Reports Second Quarter 2019 Operating and Financial Results GlobeNewswire Inc. - 8/6/2019 7:00:00 AM
Antares Pharma to Report Second Quarter 2019 Financial and Operating Results GlobeNewswire Inc. - 7/30/2019 7:00:00 AM
H2R   Thursday, 12/05/19 02:33:12 PM
Re: None
Post # of 4747 
SOS continues to be Bullish on ATRS

A new article with Larry's projections is out today:

https://smithonstocks.com/antares-detailed-sales-and-earnings-projections-for-2020-2021-and-2022-atrs-buy-4-86/

He gives his assumptions on the revenue and P/E as his best estimates.

Quote:
Management would not opine on any of my projections.



In my experience, Larry tends to be pretty good with his estimates.

Best of luck with your investments!
(This one has been good to me :)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist